My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
January 2018
CLINICAL PRACTICE MANAGEMENT
CMS Launches Data Submission System

The Centers for Medicare and Medicaid Services has launched a new data submission system for eligible clinicians participating in the Merit-based Incentive Payment System track of the Quality Payment Program. The data submission system aims to streamline data submission processes for the Quality, Improvement Activities, and Advancing Care Information performance categories as well as providing clinicians real-time initial scoring on the data they have uploaded into the new system.

Clinicians may start uploading their 2017 MIPS data now until the deadline, March 31, 2018, to avoid payment penalties for non-reporting.

IDSA has created a MIPS Data Submission Eligibility flow chart for members to determine if they are eligible to submit MIPS data using the new submission mechanism.

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


PATIENT CARE & SCIENCE
NIH Considers Next Generation Researchers Initiative Recommendations
Online Database of C. diff Providers
POLICY & ADVOCACY
Why We Should be Concerned about Cuts to 340B Drug Pricing Program
CLINICAL PRACTICE MANAGEMENT
CMS Launches Data Submission System
GLOBAL ID
Science Speaks 2017 Wrap Up
EDUCATION & RESOURCES
His Health Educational Resources: IDSA/HIVMA Accredited Courses
OFID Podcast: ID Diagnostic Test All-Star Draft
FROM THE PRESIDENT
President's Message
TOP STORIES
Federal Funding Update
Eligibility Criteria Now Available for LEAP Fellowship
Journal Club
Invest in Our Path Forward with the IDSA Foundation
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.